Market Introduction
Biopsy is a medical examination conducted by surgeons or radiologists to evaluate and eliminate cancer tissues. A tissue sample is taken to diagnose the disease, especially when a patient is presumed to have cancer. Different types of biopsies used in cancer diagnosis include skin biopsy, vacuum biopsy, fine needle aspiration, shave biopsy, incision and excision biopsy, needle biopsy, and others.
Market Overview and Dynamics
The Asia Pacificbiopsy devicesmarket is to reach US$ 744.80 Mn by 2027 from US$ 440.80 Mn in 2019; it is anticipated to grow at a CAGR of 6.9% during 2019–2027. Factors such as surging prevalence of cancer, and growing number of government initiatives are expected to boost the growth of the biopsy devices market in the coming years. However, the market is likely to get impacted by the risk factor such as limitations associated to biopsy devices during the forecast period.
Key Market Segments
In terms of product, the needle-based biopsy segment accounted for the largest share of the Asia Pacificbiopsy devicesmarket in 2019. The breast biopsysegment accounted for the largest share of the market, by application, in 2019. In terms of enduser, the ultrasound-guided biopsy segment held the most significant share of the marketin2019.
Major Sources and Companies Listed
Several major primary and secondary sources associated with the Asia Pacificbiopsy devicesmarket report are theWorld Health Organization (WHO), National Center for Biotechnology Information (NCBI),Globocan report, andso on.
Reasons to buy report
ASIA PACIFICBIOPSY DEVICESMARKET SEGMENTATION
By Product
By Application
By Technology
By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 440.80 Million |
| Market Size by 2027 | US$ 744.80 Million |
| CAGR (2019 - 2027) | 6.9% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Biopsy Devices Market is valued at US$ 440.80 Million in 2019, it is projected to reach US$ 744.80 Million by 2027.
As per our report Asia Pacific Biopsy Devices Market, the market size is valued at US$ 440.80 Million in 2019, projecting it to reach US$ 744.80 Million by 2027. This translates to a CAGR of approximately 6.9% during the forecast period.
The Asia Pacific Biopsy Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Biopsy Devices Market report:
The Asia Pacific Biopsy Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Biopsy Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Biopsy Devices Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Biopsy Devices Market
